Gordon Sanghera
Founder bei OXFORD NANOPORE TECHNOLOGIES PLC
Vermögen: 16 Mio $ am 31.03.2024
Profil
Gordon Sanghera gründete Oxford Nanopore Technologies Plc und Oxford NanoLabs Ltd. Derzeit ist Dr. Sanghera Vorstandsvorsitzender und Direktor bei Oxford Nanopore Technologies Plc. Zuvor war er Forschungsdirektor bei Abbott Laboratories und Leiter für Forschung und Entwicklung bei MediSense, Inc. (einer Tochtergesellschaft von Abbott Laboratories) und Chief Executive Officer bei Oxford NanoLabs Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2024 | 10 452 293 ( 1,22% ) | 16 Mio $ | 31.03.2024 |
Aktive Positionen von Gordon Sanghera
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Founder | 01.01.2005 |
Ehemalige bekannte Positionen von Gordon Sanghera
| Unternehmen | Position | Ende |
|---|---|---|
Oxford NanoLabs Ltd.
 Oxford NanoLabs Ltd. Medical SpecialtiesHealth Technology Oxford NanoLabs Ltd. develops nanopore technology to power a revolution in DNA analysis. It develops products for applications in genomics, pharmacogenomics and high thoroughput drug discovery as well as for the home defence and security sectors. The company was founded by Hagan Bayley in 2005 and is headquartered in Kidlington, UK. | Chief Executive Officer | 15.01.2009 |
MediSense, Inc.
 MediSense, Inc. Medical SpecialtiesHealth Technology MediSense, Inc. provides blood-glucose monitoring systems. Its products are used to monitor sugar levels in diabetes people. The company was founded in 1996 and is located in Bedford, MA | Chief Tech/Sci/R&D Officer | - |
| ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Gordon Sanghera
| University of Cardiff | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
MediSense, Inc.
MediSense, Inc. Medical SpecialtiesHealth Technology MediSense, Inc. provides blood-glucose monitoring systems. Its products are used to monitor sugar levels in diabetes people. The company was founded in 1996 and is located in Bedford, MA | Health Technology |
Oxford NanoLabs Ltd.
Oxford NanoLabs Ltd. Medical SpecialtiesHealth Technology Oxford NanoLabs Ltd. develops nanopore technology to power a revolution in DNA analysis. It develops products for applications in genomics, pharmacogenomics and high thoroughput drug discovery as well as for the home defence and security sectors. The company was founded by Hagan Bayley in 2005 and is headquartered in Kidlington, UK. | Health Technology |
